According to GlobalData’s medical device pipeline database, 388 Clinical Decision Support Systems devices are in various stages of development globally. GlobalData’s report Clinical Decision Support Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 298 are in active development, while the remaining 103 are in an inactive stage of development. There are 161 products in the early stages of development, and the remaining 137 are in the late stages of development.
Clinical Decision Support Systems (CDSS) are software tools which assist healthcare professionals with decision-making by consolidating a medical knowledge base with patient information to produce case-specific advice. They se systems use pre-established rules and guidelines to integrate clinical data from multiple sources and generate alerts and treatment suggestions.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Clinical Decision Support Systems pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Clinical Decision Support Systems devices. Overall, most of these Clinical Decision Support Systems pipeline devices are being developed by private entities.
Key players involved in the active development of Clinical Decision Support Systems include Oncoradiomics, Shanghai Pulse Medical Technology, Anumana, InformAI, PD Theranostics, Voluntis, Telix Pharmaceuticals, Perspectum, InsightRX and FIGUR8.
For a complete picture of the developmental pipeline for Clinical Decision Support Systems devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.